US FDA to hold advisory meeting to review Grail's multi-cancer test
07/08/2026 16:10
US FDA to hold advisory meeting to review Grail's multi-cancer test Aug 7 (Reuters) - Grail GRAL.O said on Friday the US FDA plans to hold a meeting of outside experts to review its multi-cancer screening test Galleri in September.
(Reporting by Sneha S K; Editing by Vijay Kishore)
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM